Kimberly Clovis, NP
Nurse Practitioner · Virginia Beach, VANPI 1144931536
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Mannkind Corporation at 46.7% of the total. Reporting peaked in 2024 at $8,526 and has fallen 64.4% since, to $3,034 in 2025. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 323 payments — averaging $43.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mannkind Corporation$7K
- Lilly USA, LLC$946
- Novo Nordisk$685
- Dexcom, Inc.$585
- Bayer$559
- Corcept Therapeutics$536
- plus $4K from 31 others
What the payments were for
- Consulting fees$5,10036%
- Speaking & faculty fees$4503%
- Food & beverage$8,25659%
- Education$200%
- Gifts$590%
- Other$1101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mannkind Corporation | 28 | $6,534 |
| Lilly USA, LLC | 53 | $946 |
| Novo Nordisk | 28 | $685 |
| Dexcom, Inc. | 6 | $585 |
| Bayer | 21 | $559 |
| Corcept Therapeutics | 22 | $536 |
| BETA Bionics, Inc. | 16 | $385 |
| Insulet Corporation | 10 | $380 |
| Xeris Pharmaceuticals, Inc. | 18 | $371 |
| Abbott | 4 | $312 |
| Sanofi-aventis U.S. LLC | 12 | $265 |
| Medtronic | 8 | $265 |
| Radius Health, Inc. | 11 | $258 |
| Boehringer Ingelheim | 13 | $232 |
| Amgen | 10 | $210 |
| Tandem Diabetes Care, Inc. | 4 | $183 |
| Sequel Med Tech, LLC | 1 | $160 |
| Kyowa Kirin, Inc. | 7 | $147 |
| Cequr Corporation | 3 | $130 |
| Endo USA, Inc. | 6 | $122 |
| Novartis | 6 | $103 |
| Recordati_rare_diseases_inc. | 5 | $82 |
| Neurocrine Biosciences, Inc. | 3 | $74 |
| Antares Pharma, Inc. | 4 | $59 |
| Ascendis Pharma Endocrinology Inc | 3 | $57 |
| Pfizer | 3 | $47 |
| AstraZeneca | 2 | $42 |
| AbbVie | 3 | $40 |
| Rhythm Pharmaceuticals, Inc. | 2 | $40 |
| Nevro Corp. | 2 | $35 |
| Tolmar, Inc. | 2 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Lifescan, Inc. | 1 | $23 |
| Ascensia Diabetes Care US Inc. | 1 | $21 |
| Merck | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFREZZA$5,787
- iLet Bionic Pancreas$316
- DEXCOM G6 TRANSMITTER$285
- Kerendia$245
- TWIIST$160
- t:slim X2 Insulin Pump with Control-IQ$140
- MOUNJARO$125
- Wegovy$124
- FREESTYLE COPILOT$110
- Korlym$102
- MINIMED 780G$101
How this compares
$13,995 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 235 | $340,565 |
| JardianceEmpagliflozin | 192 | $275,565 |
| MounjaroTirzepatide | 111 | $208,604 |
| TrulicityDulaglutide | 126 | $167,079 |
| Humalog Kwikpen U-200Insulin Lispro | 37 | $120,095 |
| AfrezzaInsulin Regular, Human | 43 | $97,882 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 111 | $90,286 |
| V-Go 20Sub-Q Insulin Device, 20 Unit | 91 | $64,809 |
| V-Go 40Sub-Q Insulin Device, 40 Unit | 68 | $53,775 |
| JanuviaSitagliptin Phosphate | 43 | $45,064 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 41 | $39,885 |
| HumalogInsulin Lispro | 140 | $39,793 |
| V-Go 30Sub-Q Insulin Device, 30 Unit | 59 | $37,469 |
| Tresiba Flextouch U-100Insulin Degludec | 54 | $36,710 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 51 | $35,869 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro, Humulin 70-30 | $946 | $426,203463 claims |
| Novo NordiskOzempic, Fiasp, Novolog | $685 | $389,599317 claims |
| Boehringer IngelheimJardiance | $232 | $275,565192 claims |
| Mannkind CorporationAfrezza | $6,534 | $97,88243 claims |
| MerckJanuvia, Janumet, Janumet Xr | $18 | $74,72170 claims |
| AstraZenecaFarxiga | $42 | $26,36322 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $27 | $1,06355 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Virginia Beach
- Kristin AustriaVirginia Beach$26K
- Lisa WalkerVirginia Beach$11K
- Barbara McCrayVirginia Beach$10K
- Matthew GilbertVirginia Beach$10K
- Colette BrooksVirginia Beach$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.